Patents for A61P 35 - Antineoplastic agents (221,099)
08/2010
08/18/2010EP2217231A1 Use of 3-(indolyl)- or 3-(azaindolyl)-4-arylmaleimide derivatives in leukemia management
08/18/2010EP2217227A2 Treatment of breast cancer with a parp inhibitor alone or in combination with anti-tumor agents
08/18/2010EP2217223A2 Methods and compositions for measuring wnt activation and for treating wnt-related cancers
08/18/2010EP2217209A1 Novel thermosensitive liposomes containing therapeutic agents
08/18/2010EP2004696B1 Antibody molecules specific for fibroblast activation protein and immunoconjugates containing them
08/18/2010EP1984350B1 Pyrimidine derivatives used as pi-3 kinase inhibitors
08/18/2010EP1767633B1 Novel polypeptide useful for diagnosis and treatment of cancer
08/18/2010EP1723131B1 Crystalline polymorphs of a cxc-chemokine receptor ligand
08/18/2010EP1461360B1 Conjugates comprising an antibody specific for the ed-b domain of fibronectin and their use for the detection and treatment of tumours
08/18/2010EP1411910B1 (+)-cycloolivil as antioxidant obtained from stereospermum personatum
08/18/2010EP1320526B1 Pharmaceutically active benzsulfonamide derivatives as inhibitors of protein junkinases
08/18/2010EP0956865B2 MEDICINES COMPRISING Rho KINASE INHIBITOR
08/18/2010EP0910246B1 Use of mutant alkyltransferases for gene therapy to protect from toxicity of therapeutic alkylating agents
08/18/2010EP0723402B1 Senescent cell-derived inhibitors of dna synthesis
08/18/2010CN1961908B Anti-tumor pharmaceutical composition and preparation method thereof
08/18/2010CN1922182B Pyrrolotriazine compounds as kinase inhibitors
08/18/2010CN1830960B 10-phenyl hydroisoindolone type compounds, preparation method and use thereof
08/18/2010CN1744906B Auxiliary agent to be used in cancer therapy by dielectric heating and cancer therapy method
08/18/2010CN1704121B Anti-angiogenic compositions and methods of use
08/18/2010CN101809162A anti-glypican-3 antibody having improved kinetics in plasma
08/18/2010CN101809148A Novel immunotherapy against neuronal and brain tumors
08/18/2010CN101809037A Human antibodies to human cd20 and method of using thereof
08/18/2010CN101809020A Perharidines as CDK inhibitors
08/18/2010CN101809017A phthalazinone derivatives
08/18/2010CN101809002A morpholino pyrimidine derivatives used in diseases linked to mtor kinase and/or pi3k
08/18/2010CN101808996A Nicotinamide derivatives, preparation thereof and therapeutic use thereof
08/18/2010CN101808693A Triazine kinase inhibitors
08/18/2010CN101808668A Active targeting type polymeric micelle carrying drug enclosed therein and medicinal composition
08/18/2010CN101808666A Anti-mitotic agent and aurora kinase inhibitor combination as anti-cancer treatment
08/18/2010CN101808664A Immunosuppression weaning agent comprising tumor cell and antitumor agent using the same
08/18/2010CN101808654A Compounds extracted from palm oil mill effluent for the treatment of cancer, compositions thereof and methods therewith
08/18/2010CN101808651A polymer conjugate of steroid
08/18/2010CN101808648A Pharmaceutical composition and pharmaceutical kit for the treatment of hepatocellular carcinoma
08/18/2010CN101808644A Polymerase inhibitors and the use thereof for the treatment of tumors
08/18/2010CN101808636A Treatment of melanoma
08/18/2010CN101808629A Method for activating regulatory T-cells
08/18/2010CN101805738A Peculiar p53 mutated protein-p53N236S of ALT tumor caused by progeria syndrome and application thereof
08/18/2010CN101805737A Ribonucleic acid with liver cancer-related gene DLK1as target and application thereof
08/18/2010CN101805736A Ribonucleic acid with liver cancer-related gene DLK1 as target and application thereof
08/18/2010CN101805724A Targeting WWOX (WW domain-containing oxidoreductase) gene recombinant adenovirus and preparation method and application thereof
08/18/2010CN101805699A Method for preparing gliocladicillin C and application thereof
08/18/2010CN101805412A Water-soluble low-molecular-weight cordyceps polysaccharide with anti-tumor activity, preparation method and application thereof
08/18/2010CN101805408A Antitumor and thrombolytic double-effect chimeric protein, preparation method thereof and use thereof
08/18/2010CN101805390A Tripterine derivate and use thereof
08/18/2010CN101805385A Neoflavonoid compounds separated and purified from Tridax procumbens and preparation method thereof
08/18/2010CN101805384A Novel lycoris quinolone alkaloid and preparation method and application thereof
08/18/2010CN101805383A Strictosidine lactam derivatives and preparation method and use thereof
08/18/2010CN101805355A Thienopyridone derivative, preparation method and uses thereof
08/18/2010CN101805351A Fungi epoxy diene acid derivative 4-NDM and synthesis method and purpose thereof
08/18/2010CN101805349A Furan-azo- [3,2-g] chromene compound and application thereof
08/18/2010CN101805338A Oxadiazole-based piperazine derivative and application thereof
08/18/2010CN101805333A Cyclorotenoid, preparation method and application thereof
08/18/2010CN101805330A 2-alkyl-benzimidazole-1-acetyl hydrazone and synthesis method and application thereof
08/18/2010CN101805328A epothilone derivatives
08/18/2010CN101805325A Novel lignan compound and application thereof
08/18/2010CN101805309A Benzamide derivatives useful as histone deacetylase inhibitors
08/18/2010CN101805290A Aminosulfonyl pyrazol compounds and applications thereof
08/18/2010CN101805285A Nicotinic acid-contained curcumin ester derivative and preparation method and application thereof
08/18/2010CN101805247A Fluorine marking cyclofenil derivative as well as reference compound, midbody, preparation method and application thereof
08/18/2010CN101805246A Urushiol compound and medicinal composition thereof, preparation method and application thereof
08/18/2010CN101804210A Gene medicine for inhibiting lung cancer metastasis and pulmonary metastases
08/18/2010CN101804209A PEDF (Pigment Epithelial Derived Factor) gene PLGA nano compound as well as preparation method and use thereof
08/18/2010CN101804208A Application of miR-451 in preparing medicine for treating non-small cell lung cancer
08/18/2010CN101804207A New application of miR-223
08/18/2010CN101804198A Combination containing fotemustine
08/18/2010CN101804197A Medicament compound for treating cancer bone metastasis and purposes thereof
08/18/2010CN101804192A CTLA4lg and derivatives thereof used for resisting tumors
08/18/2010CN101804175A Anti-cancer Chinese medicinal powder and preparation method thereof
08/18/2010CN101804171A Medicine for treating gastric cancer
08/18/2010CN101804145A Garlic oil enteric pellet capsule and preparation method thereof
08/18/2010CN101804142A Traditional Chinese medicine composition for treating carcinoma of uterine body
08/18/2010CN101804132A Sansevieria trifasciata saponin, preparation method and application thereof
08/18/2010CN101804129A Method for extracting natural tea polyphenol
08/18/2010CN101804126A Application of traditional Chinese medicine composition in treating qi-blood deficiency and spleen-kidney deficiency and preparation method thereof
08/18/2010CN101804096A Method for extracting purified total alkaloid of strychnos nux-vomica and application thereof in pharmacy
08/18/2010CN101804086A Preparation method of fermented red ginseng product
08/18/2010CN101804082A Method for identifying cordyceps sinensis powder through microscopic dyeing
08/18/2010CN101804074A Traditional Chinese medicine for treating esophagus cancer
08/18/2010CN101804050A Treatment of proliferative diseases with epothilone derivatives and radiation
08/18/2010CN101804046A Application of myricetin for Janus kinase inhibitor medicines
08/18/2010CN101804032A Preparation method of 5-fluorouracil-wrapped biodegradable polylactic acid/nano-hydroxyapatite compound microspheres
08/18/2010CN101804025A Aqueous solution injection for picoplatin
08/18/2010CN101804021A Preparation method of polyene-containing taxol nanoparticle mixed micelle preparation and freeze-drying agent
08/18/2010CN101803531A China cryptoporus sinensis and solid cultural method and application thereof
08/18/2010CN101367819B 5-substituent-2-(4-substituted phenyl)-6,7-dihydrogen pyrazole-[1,5-a]pyrazine-4(5H)-ketone derivant and uses thereof
08/18/2010CN101348569B Organotin coordination polymeric compound, preparation and use thereof
08/18/2010CN101342158B Application of two bromine phenolic compounds in preparing medicament for treating malignant tumor
08/18/2010CN101338303B Adenovirus marked by radionuclide
08/18/2010CN101284861B Triterpenoid saponin compounds, preparation method and use
08/18/2010CN101229362B Use of thymulin on preparing protective medicine of antineoplastic agent, tumour physiatry and chemotherapeutic medicine
08/18/2010CN101199507B Application of furan diene and derivatives in preparing therapeautic cancer medicament
08/18/2010CN101167741B Sulforaphane and platinum medicine anti-cancer combination preparation
08/18/2010CN101164534B Application of curcumin in preparing tumor multi-medicine drug-resistant prevention agent
08/18/2010CN101116699B Medicine for treating tumor
08/18/2010CN101092363B Compound of lignanin aryl tetrahydronaphthalene, preparation method and application
08/18/2010CN101007047B An antitumor medicine composition and its preparation method
08/17/2010US7777060 Cis-(3-[2-(2-cyano-ethoxy)-ethoxy]-propionitrile)dichloroplatinum (II); Cis-bis(3-methoxy-propionitrile)dichloroplatinum (II); lipophilicity; modulate replication or transcription of DNA or translation or function of RNA; anticancer agents
08/17/2010US7777057 Derivatives of dioxan-2-alkyl carbamates, preparation thereof and application thereof in therapeutics
08/17/2010US7777050 N3 alkylated benzimidazole derivatives as MEK inhibitors
08/17/2010US7777010 Recovering preferential protein from library; obtain genetically engineered cells, transform with vector coding preferential protein, express protein, isolate protein